Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

D Ettehad, CA Emdin, A Kiran, SG Anderson… - The Lancet, 2016 - thelancet.com
Background The benefits of blood pressure lowering treatment for prevention of
cardiovascular disease are well established. However, the extent to which these effects …

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta …

S Czernichow, A Zanchetti, F Turnbull… - Journal of …, 2011 - journals.lww.com
Background The benefits of reducing blood pressure are well established, but there remains
uncertainty about whether the magnitude of the effect varies with the initial blood pressure …

Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis

M Brunström, B Carlberg - JAMA internal medicine, 2018 - jamanetwork.com
Importance High blood pressure (BP) is the most important risk factor for death and
cardiovascular disease (CVD) worldwide. The optimal cutoff for treatment of high BP is …

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

X Xie, E Atkins, J Lv, A Bennett, B Neal, T Ninomiya… - The Lancet, 2016 - thelancet.com
Background Recent hypertension guidelines have reversed previous recommendations for
lower blood pressure targets in high-risk patients, such as those with cardiovascular …

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

Blood Pressure Lowering Treatment Trialists' … - The Lancet, 2014 - Elsevier
Background We aimed to investigate whether the benefits of blood pressure-lowering drugs
are proportional to baseline cardiovascular risk, to establish whether absolute risk could be …

How much lowering of blood pressure is required to prevent cardiovascular disease in patients with and without previous cardiovascular disease?

D Canoy, M Nazarzadeh, E Copland, Z Bidel… - Current cardiology …, 2022 - Springer
Abstract Purpose of Review To review the recent large-scale randomised evidence on
pharmacologic reduction in blood pressure for the primary and secondary prevention of …

Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk–overview and meta-analyses of …

C Thomopoulos, G Parati, A Zanchetti - Journal of hypertension, 2014 - journals.lww.com
Background: Randomized controlled trials (RCTs) of blood pressure (BP) lowering lend
themselves to be meta-analyzed to help providing evidence-based recommendations for …

Blood pressure reduction and cardiovascular outcomes: past, present, and future

G Mancia - The American journal of cardiology, 2007 - Elsevier
Hypertension has not always been recognized as a harbinger of cardiovascular
complications and premature death. Only 70 years ago, hypertension was considered the …

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from …

MR Law, JK Morris, NJ Wald - Bmj, 2009 - bmj.com
Objectives To determine the quantitative efficacy of different classes of blood pressure
lowering drugs in preventing coronary heart disease (CHD) and stroke, and who should …